Who makes Temisartan?

Temisartan is developed by Third Military Medical University.

What development phase is Temisartan in?

Temisartan is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Temisartan

Third Military Medical University · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Temisartan
Sponsor	Third Military Medical University
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin (PHASE1)
Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia (PHASE3)
Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Temisartan CI brief — competitive landscape report
Temisartan updates RSS · CI watch RSS
Third Military Medical University portfolio CI